Key result
The PERIMOUNT pericardial bioprosthesis demonstrated higher overall survival at 15 years compared to the supra-annular porcine valve after aortic valve replacement.
Why the study?
Does a pericardial bioprosthesis improve 15-year survival and freedom from structural deterioration compared to a supra-annular porcine bioprosthesis in patients undergoing aortic valve replacement?
Cohort (n=3,253)
Does a pericardial bioprosthesis improve 15-year survival and freedom from structural deterioration compared to a supra-annular porcine bioprosthesis in patients undergoing aortic valve replacement?
Both supra-annular porcine and pericardial bioprostheses provide satisfactory 15-year clinical performance, though the pericardial valve demonstrated better freedom from structural deterioration in patients aged ≤60 years.
Answers are grounded in this paper and cite their sources.
May support pericardial over porcine bioprosthesis selection in AVR; extends observational comparisons but remains hypothesis-generating.
The second-generation Carpentier-Edwards bioprostheses, the supra-annular porcine valve and the PERIMOUNT pericardial valve, have been evaluated longitudinally for several years. This study compared clinical performance over 15 years. Aortic valve replacement was performed with a supra-annular porcine valve in 1,823 patients (group 1) aged 19-89 years (mean, 68.9 +/- 10.9 years) and with a PERIMOUNT pericardial bioprosthesis in 1,430 patients (group 2) aged 16-90 years (mean, 69.5 +/- 10.4 years). The groups were similar except for concomitant coronary artery bypass in 43% of group 1 and 18% of group 2 ( p < 0.001). Overall survival at 15 years was 29.3% +/- 1.5% for group 1 and 35.2% +/- 3.1% for group 2 ( p = 0.0009). The actual freedom from valve-related mortality was 88.5% +/- 0.9% for group 1 and 84.9% +/- 1.7% for group 2. The actual freedom from structural valve deterioration at 15 years was similar overall, and for patients aged > 60 years, between the groups, but was dissimilar (group 2 > group 1) for age </= 60 years. The predictors of structural valve deterioration were valve type (group 1 > group 2), sex (male > female), age, and concomitant coronary artery bypass. Both bioprostheses provided satisfactory clinical performance at 15 years after aortic valve replacement.
No takes yet. Share an insight, caveat, or question.
Jamieson et al. (2006) conducted a cohort in Aortic valve replacement (n=3,253). PERIMOUNT pericardial bioprosthesis vs. Supra-annular porcine valve was evaluated on Overall survival at 15 years (p=0.0009). The PERIMOUNT pericardial bioprosthesis demonstrated higher overall survival at 15 years compared to the supra-annular porcine valve after aortic valve replacement.
Synapse has enriched 10 related papers. Consider them for comparative context: